Format

Send to

Choose Destination
See comment in PubMed Commons below
Magnes Res. 2011 Dec;24(4):156-62. doi: 10.1684/mrh.2011.0299.

The role of magnesium in type 2 diabetes: a brief based-clinical review.

Author information

1
Biomedical Research Unit, Mexican Social Security Institute, Predio Canoas 100, Col. Los Angeles, 34067 Durango, Dgo. Mexico.

Abstract

A growing body of evidence from experimental studies that shows the essential role that magnesium exerts on glucose metabolism has been developed in last years, strongly suggesting that magnesium could plays an important roles in the reduction of the risk of developing type 2 diabetes. In the clinical setting, large epidemiological studies show that low dietary magnesium intake is associated with the increased risk of developing type 2 diabetes; however, results from randomized controlled clinical trials that have evaluated the beneficial effects of magnesium supplementation on glucose metabolism and insulin sensitivity are controversial. In this article we searched (in the electronic databases of Medline, Embase, and the Cochrane Controlled Trials Register up to June 2011) the evidence derived from epidemiological studies and clinical trials, about the relationship between magnesium and type 2 diabetes. The body of evidence from epidemiological studies consistently shows a strong inverse relationship between dietary magnesium intake and the risk of developing T2D; however, results from clinical trials are scarce and controversial.

PMID:
22198525
DOI:
10.1684/mrh.2011.0299
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Libbey Eurotext
    Loading ...
    Support Center